Oura agrees to buy Counsel Health in $625 million cash deal
Oura has agreed to acquire Counsel Health, extending its wearable-health business into physician-supervised care. The November 10 announcement describes a definitive agreement rather than a completed acquisition. Oura
Latham & Watkins, which represents Oura, puts the purchase price at US$625 million in cash, subject to adjustments. The law firm expects the transaction to close before the end of the calendar year. Oura’s announcement describes the timing as near year-end. Latham & Watkins
The companies have worked together since May. Oura says the combination is intended to connect information from its ring and app with Counsel’s medical AI and licensed doctors. Physicians supervise clinical decisions and can provide diagnosis, treatment, lab orders and prescriptions when appropriate.
Oura says physicians can access a member’s ring data and past conversations only with permission. Counsel will continue working with health plans and health systems, including services for people without an Oura Ring. The existing experience remains available for exploration through Oura Labs while broader integration is developed.
The distinction between a wellness signal and clinical judgment is central to this deal. A device can supply a continuous record, but that does not itself establish a diagnosis or prove better outcomes. The announcements offer a strategic rationale and planned integration, not independent clinical evidence of benefits from the combined service.
For members, the next useful disclosures concern the completed transaction, the rollout of the integrated service and the terms governing access. Until then, neither the agreement nor its price should be read as a promise that every ring owner already has the proposed care experience.
Sources and citations
Revision history
Published .